ThermoGenesis Holdings Updates 510(K) Listing with the FDA to Include Its Next Generation ...

RANCHO CORDOVA, Calif., Dec. 10, 2019 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that it has completed the development process and submitted a Letter to the Design History File and updated the device listing with the U.S. Food and Drug Administration (FDA) for the PXP®-1000 System. The PXP-1000 is the next generation of ThermoGenesis'...This story is related to the following:Clinical Medical Equipment
Source: Industrial Newsroom - Health, Medical and Dental Supplies - Category: Medical Devices Source Type: news